PCOS Is Now PMOS: What the Name Change Means For Black Women

For years, many women believed that if they didn’t have ovarian cysts, they didn’t have PCOS. That misunderstanding has contributed to delayed diagnoses, confusion, and women feeling dismissed when their symptoms didn’t fit what they thought the condition was supposed to look like.

Now, that may finally be changing.

As of May 12, 2026, Polycystic ovary syndrome (PCOS) has officially been renamed polyendocrine metabolic ovarian syndrome (PMOS). Experts hope that this shift will better reflect the true complexity of the condition and help more women get diagnosed earlier. 

The new name matters because PCOS has never just been about cysts on the ovaries. Instead, the condition can involve hormone imbalances, irregular periods, fertility challenges, acne, excessive hair growth, hair thinning, insulin resistance, type 2 diabetes risk, and cardiovascular complications (Holcombe, 2026). 

According to the World Health Organization, an estimated 10% to 13% of reproductive-age women worldwide are impacted by PCOS, but nearly 70% remain undiagnosed. This statistic is especially important for Black women, who are often underdiagnosed, misdiagnosed, or dismissed when reporting hormone-related symptoms.

Why the Name Change Matters

The renaming process took 14 years and involved collaboration between 56 organizations, researchers, healthcare professionals, and people living with the condition (Endocrine Society, 2026).

Researchers behind the change say the term “polyendocrine metabolic ovarian syndrome” better reflects the fact that this is an endocrine and metabolic condition rather than an ovarian issue.

The “polyendocrine” portion of the new name recognizes that PMOS affects multiple hormone systems throughout the body. Experts hope this broader framing will encourage more comprehensive care and greater awareness across medical specialties, rather than limiting conversations to reproductive health alone (Holcombe, 2026).

According to researchers published in The Lancet, the previous name contributed to “delayed diagnosis, fragmented care and stigma” because it failed to accurately describe the condition (Astor, 2026).

Historically, many women with PCOS have primarily been offered birth control to manage symptoms. While birth control can absolutely help some women, experts note that it doesn’t fully address the metabolic and endocrine effects associated with the condition (Astor, 2026).

Researchers hope the updated name will lead to more holistic treatment approaches, more funding, and more research into therapies specifically designed for PMOS rather than relying on treatments originally created for other conditions (Astor, 2026).

How This Could Help Women Get Diagnosed Earlier

For many women, getting answers about hormonal symptoms can take years. Symptoms like irregular periods, weight changes, fatigue, hair thinning, acne, or infertility are often treated individually instead of being connected as part of a larger hormonal condition. The PMOS name change may help providers look at the full picture sooner.

Experts also say the change could encourage more screening for metabolic and cardiovascular complications linked to the condition, something that has often been overlooked when treatment focused only on reproductive symptoms (Astor, 2026).

Historically, many women with PCOS have primarily been offered birth control to manage symptoms. While birth control can absolutely help some women, experts note that it doesn’t fully address the metabolic and endocrine effects associated with the condition (Astor, 2026).

Researchers hope the updated name will lead to more holistic treatment approaches, more funding, and more research into therapies specifically designed for PMOS rather than relying on treatments originally created for other conditions (Astor, 2026).

What PMOS Means for Black Women

Black Girl Vitamins Medical Advisor Dr. Byranne-Standifer Barrett explained what this change could mean for Black women. 

“The renaming of PCOS to polyendocrine metabolic ovarian syndrome (PMOS) is more than a vocabulary update — it’s a long-overdue correction. For Black women, who face 42 to 48 percent lower odds of being diagnosed  and are routinely told their symptoms are “normal,” stress-related, or just a weight issue, the old name kept the focus on cysts many of us never had. PMOS names what’s actually happening: a complex hormonal, metabolic, and cardiovascular condition. That shift matters, because it opens the door to earlier diagnoses, more accurate care, and fewer years of being dismissed”

References

Astor, M. (2026). P.C.O.S. Has Been Renamed P.M.O.S. Here’s What to Know. The New York Times.

Endocrine Society. (2026). PCOS Name Change.

Holcombe, M. (2026). PCOS renamed PMOS in effort to better reflect condition’s complexity. CNN.